Cargando…
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection
BACKGROUND AND OBJECTIVE: Clostridium difficile infection (CDI) is associated with high management costs, particularly in recurrent cases. Fidaxomicin treatment results in lower recurrence rates than vancomycin and metronidazole, but has higher acquisition costs in Europe and the USA. This systemati...
Autores principales: | Burton, Hannah E., Mitchell, Stephen A., Watt, Maureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656734/ https://www.ncbi.nlm.nih.gov/pubmed/28875314 http://dx.doi.org/10.1007/s40273-017-0540-2 |
Ejemplares similares
-
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
por: van Engen, Anke, et al.
Publicado: (2015) -
Management of inflammatory bowel disease with Clostridium difficile infection
por: D’Aoust, Julie, et al.
Publicado: (2017) -
Statins & risk of Clostridium difficile infection: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2019) -
Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023) -
Economic evaluation of interventions designed to reduce Clostridium difficile infection
por: Brain, David, et al.
Publicado: (2018)